A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the Food and Drug Administration's jurisdiction over certain tobacco products, and to protect jobs and small businesses involved in the sale, manufacturing, and distribution of traditional and premium cigars.

# Summary of S 3922 **What the bill would do:** This bill would modify how the FDA regulates tobacco products by clarifying its authority over certain tobacco items and creating protections specifically for the cigar industry. The legislation aims to reduce regulatory burdens on businesses that manufacture, sell, and distribute traditional and premium cigars. **Who it affects:** The bill primarily impacts small cigar manufacturers, distributors, and retailers, as well as workers employed in these sectors. It could also affect cigar consumers and the broader tobacco regulatory landscape overseen by the FDA. **Current status:** S 3922 is currently in committee, meaning it has been introduced but has not yet been debated or voted on by the full Senate.

The bill was sponsored by Senator Ashley Moody (R-FL). Without additional details about specific provisions, the exact nature of the FDA clarifications and protections remains unclear, but the bill appears designed to carve out certain regulatory exemptions or modifications for the cigar industry compared to other tobacco products.